Description

Senior pharmaceutical commercial executive with 23 years at Sandoz (ex-Novartis Group), specialising in commercial strategy, business turnarounds and market entry across CEEMEA markets.

I help pharma and biotech companies accelerate growth in complex, resource-constrained environments — designing go-to-market models, creating growth strategies, optimising portfolios and building the commercial case for new market entry.

My track record includes managing $50m P&L as a Country Head, leading commercial operations for a $200m+ commercial cluster across 15+ markets in Africa, Middle East and Turkey, turning around underperforming franchises, launching biosimilars and branded generics, and managing multi-market BD&L partnerships. I bring both the regional picture and on-the-ground commercial realities — equally effective at cluster strategy level and country execution.

Available for fractional, interim and project-based mandates.

Industry field of expertise

Languages

English
Native or bilingual
Slovenian
Native or bilingual
Serbian
Native or bilingual
German
Fluent
Portuguese
Conversational
French
Basic

Workplace preferences

Remote only

Primarily works remotely

Self-employed
Independent Pharmaceutical Commercial Advisor
PHARMACEUTICALS INDUSTRY
June 2025 - Today (1 year)
• Providing senior advisory support to pharma and biotech companies on emerging market entry, commercial model redesign, portfolio prioritisation and performance turnarounds — with particular depth across Africa, Middle East, Turkey, CEE and CIS markets.
• Advising on go-to-market model design, distributor strategy, launch planning and commercial capability development in regulated and resource-constrained environments.
Commercial strategy Go-to-market strategy
Women's Health Supplements Venture
Founder
PHARMACEUTICALS INDUSTRY
June 2025 - Today (1 year)
EU-registered | Direct-to-consumer brand targeting European markets
• Founding a supplement brand addressing female fertility, drawing on personal experience and evidence-based research. Leading all aspects of product development, regulatory compliance (food supplement classification), CMO selection and go-to-market strategy.
SANDOZ
Cluster Commercial Resource & Allocation Lead, CEE/CIS/AT/BE
PHARMACEUTICALS INDUSTRY
May 2022 - June 2025 (3 years and 1 month)
Slovenia-based | Cluster 2 strategic initiative
• Led cluster-wide commercial resource allocation initiative across CEE, CIS, Austria and Belgium — optimising budget deployment, headcount planning and portfolio focus to improve performance and ROI.
Business model